Product Program year 2025 Source: CMS Open Payments

2008T Bluestar Hemodialysis MacHine

Device Dialyzer, High Permeability With Or Without Sealed Delivery System

PDI 00840861102099

Open in the dashboard

General payments

$4,375

105 payments

Research payments

$0

0 payments

Through program year 2025, $4,375 in general payments and $0 in research payments were reported against 2008T Bluestar Hemodialysis MacHine (Dialyzer, High Permeability With Or Without Sealed Delivery System).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $1,258 34
2024 General $911 20
2023 General $592 11
2022 General $633 14
2021 General $981 26

Breakdown

Who paid General payments · program years 2021–2025
  1. Fresenius USA Marketing, Inc. $4,146 99 payments
  2. NxStage Medical, Inc. $229 6 payments
Top recipients General payments · program year 2025
  1. James Henry Nephrology · Fort Smith, AR $98 8% · 1 payment
  2. Charles Moussallem Nephrology · Fort Smith, AR $98 8% · 1 payment
  3. Dana Rabideau Nephrology · Fort Smith, AR $98 8% · 1 payment
  4. Herminio Garcia-Estrada Nephrology · Miami, FL $90 7% · 1 payment
  5. Darol Joseff Nephrology · Santa Barbara, CA $87 7% · 1 payment

The top 5 of 33 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nephrology Internal Medicine $996 81% · 22 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $62 5% · 3 practitioners
  3. Nurse Practitioner, Acute Care Nurse Practitioner $61 5% · 1 practitioner
  4. Nurse Practitioner $32 3% · 2 practitioners
  5. Vascular Surgery Surgery $21 2% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $323 26% · 9 recipients
  2. Arkansas $295 23% · 3 recipients
  3. California $232 18% · 6 recipients
  4. Texas $142 11% · 3 recipients
  5. Missouri $103 8% · 6 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

105 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record